Delivery Order SPE2DB22D1202-SPE2DB25FVGD3
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on June 16, 2025, for the supply of Lidocaine 5% Patch 30-count units, with a ceiling value of $10,834.22 and firm fixed pricing. This competitively awarded, non-set-aside delivery order is scheduled for completion by June 17, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a continuation of the company's substantial...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 5, 2025, for the supply of Lidocaine 5% Patch 30-count units, valued at $1,134.20. This firm fixed-price delivery order, which is expected to be completed by August 6, 2025, represents a continuation of AmerisourceBergen's role as a critical pharmaceutical supplier within the federal medical supply chain. The contract was competitively awarded with no set-aside designation and will be performed at...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 12, 2025, for the supply of Lidocaine 5% Patch 30s, with a ceiling value of $5,418.73. This firm fixed-price delivery order, with an ultimate completion date of September 15, 2025, represents a competitive award with no set-aside designation. The order will be performed at the company's corporate office location in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its headquarters as a...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 28, 2025, for the supply of Lidocaine 5% Patch in quantities of 30 units, with a ceiling value of $2,352.17. This is a firm fixed-price delivery order with no set-aside designation, reflecting a competitive award to the prime contractor. The order is scheduled for ultimate completion by August 29, 2025, and will be fulfilled from AmerisourceBergen's Conshohocken, Pennsylvania facility, serving the...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Lidocaine 5% Patch 30S with a ceiling value of $10,877.33. This is a firm fixed price, competitively awarded contract with no set-aside designation and an ultimate completion date of September 11, 2025. The order will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its primary operations as a major...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on August 15, 2025, for the supply of Lidocaine 5% Patch in quantities of 30 units. This is a firm fixed-price delivery order with a ceiling value of $1,029.81 and an ultimate completion date of August 18, 2025. The contract involves no set-aside designation, indicating it was awarded through open competition. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as the prime...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 12, 2025, for the supply of Lidocaine 5% Patch in quantities of 30 units, with a ceiling value of $11,041.30. This is a firm fixed-price delivery order with no set-aside designation, reflecting a competitively awarded contract. The work is scheduled for completion by September 15, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 21, 2025, for the supply of Lidocaine 5% Patch 30s at a ceiling value of $2,170.58. This is a firm fixed price delivery order with an ultimate completion date of August 22, 2025, and was awarded without a set-aside designation through competitive procurement. The product will be delivered to the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 15, 2025, for the supply of Lidocaine 5% Patch 30s, with a ceiling value of $4,961.89. This is a firm fixed price delivery order with an ultimate completion date of August 18, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award was made without a set-aside designation, indicating it was competitively awarded among qualified vendors. This delivery order is a...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Lidocaine 5% Patch 30S, with a ceiling value of $9,367.14. This firm fixed-price delivery order, awarded on August 4, 2025, with an ultimate completion date of August 5, 2025, represents a competitively awarded, non-set-aside contract. Performance will take place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- SPE2DB22D1202Indefinite Delivery Contract
- SPE2DB22D1202-SPE2DB25FVGD3Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 31, 2025, for the supply of Lidocaine 5% Patch 30s, with a ceiling value of $9,894.62. This firm fixed-price delivery order, with an ultimate completion date of August 1, 2025, represents a continuation of the company's pharmaceutical supply support to the federal government. The contract carries no set-aside designation and was competitively awarded through open procurement. Performance will be executed from the vendor's location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. This prime contract vehicle serves as a comprehensive global pharmaceutical support mechanism enabling the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. AmerisourceBergen Drug Corp's substantial IDC reflects its critical role as a major pharmaceutical distributor serving the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems with specialty medications, brand-name and generic drugs, vaccines, and related medical supplies across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $9.9k | 7/31/25 |